Bayer AG Working Capital Growth & History (BAYN)
Bayer AG's working capital was €326.0M for fiscal 2025.
View full Bayer AG company overviewBayer AG annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €326.0M | −€5.17B | −94.06% |
| 2024 | 2024-12-31 | €5.49B | −€2.61B | −32.19% |
| 2023 | 2023-12-31 | €8.10B | €5.42B | +202.65% |
| 2022 | 2022-12-31 | €2.68B | −€499.0M | −15.72% |
| 2021 | 2021-12-31 | €3.17B | €4.24B | — |
| 2020 | 2020-12-31 | −€1.07B | −€10.41B | — |
| 2019 | 2019-12-31 | €9.34B | €1.23B | +15.22% |
| 2018 | 2018-12-31 | €8.11B | −€8.37B | −50.79% |
| 2017 | 2017-12-31 | €16.48B | €4.57B | +38.37% |
| 2016 | 2016-12-31 | €11.91B | €5.07B | +74.10% |
| 2015 | 2015-12-31 | €6.84B | €117.0M | +1.74% |
| 2014 | 2014-12-31 | €6.72B | €1.72B | +34.35% |
| 2013 | 2013-12-31 | €5.00B | −€882.0M | −14.98% |
| 2012 | 2012-12-31 | €5.89B | −€791.0M | −11.84% |
| 2011 | 2011-12-31 | €6.68B | −€805.0M | −10.76% |
| 2010 | 2010-12-31 | €7.48B | — | — |
Bayer AG quarterly working capital
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €1.37B | −€2.60B | −65.41% |
| Q1 2026 | 2026-03-31 | €1.84B | — | — |
| Q4 2025 | 2025-12-31 | €326.0M | — | — |
| Q3 2025 | 2025-09-30 | €3.92B | — | — |
| Q2 2025 | 2025-06-30 | €3.97B | — | — |
Bayer AG working capital trends
Over the last five fiscal years, Bayer AG's working capital increased from −€1.07B to €326.0M, a change of €1.39B. The latest reported quarter, Q2 2026, shows €1.37B.
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...